BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23773242)

  • 1. Ribavirin is not effective against Crimean-Congo hemorrhagic fever: observations from the Turkish experience.
    Ceylan B; Calıca A; Ak O; Akkoyunlu Y; Turhan V
    Int J Infect Dis; 2013 Oct; 17(10):e799-801. PubMed ID: 23773242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran.
    Mardani M; Jahromi MK; Naieni KH; Zeinali M
    Clin Infect Dis; 2003 Jun; 36(12):1613-8. PubMed ID: 12802764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin for treating Crimean Congo haemorrhagic fever.
    Johnson S; Henschke N; Maayan N; Mills I; Buckley BS; Kakourou A; Marshall R
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012713. PubMed ID: 29869797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of ribavirin in the treatment of Crimean-Congo hemorrhagic fever in Eastern Black Sea region in Turkey.
    Koksal I; Yilmaz G; Aksoy F; Aydin H; Yavuz I; Iskender S; Akcay K; Erensoy S; Caylan R; Aydin K
    J Clin Virol; 2010 Jan; 47(1):65-8. PubMed ID: 19962342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey.
    Elaldi N; Bodur H; Ascioglu S; Celikbas A; Ozkurt Z; Vahaboglu H; Leblebicioglu H; Yilmaz N; Engin A; Sencan M; Aydin K; Dokmetas I; Cevik MA; Dokuzoguz B; Tasyaran MA; Ozturk R; Bakir M; Uzun R
    J Infect; 2009 Mar; 58(3):238-44. PubMed ID: 19246100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of patients with Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and impact of oral ribavirin therapy.
    Ergönül O; Celikbaş A; Dokuzoguz B; Eren S; Baykam N; Esener H
    Clin Infect Dis; 2004 Jul; 39(2):284-7. PubMed ID: 15307042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the crucial parameters regarding the efficacy of ribavirin therapy in Crimean-Congo haemorrhagic fever (CCHF) patients: a systematic review and meta-analysis.
    Arab-Bafrani Z; Jabbari A; Mostakhdem Hashemi M; Arabzadeh AM; Gilanipour A; Mousavi E
    J Antimicrob Chemother; 2019 Dec; 74(12):3432-3439. PubMed ID: 31369086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral ribavirin treatment on the viral load and disease progression in Crimean-Congo hemorrhagic fever.
    Bodur H; Erbay A; Akıncı E; Öngürü P; Bayazıt N; Eren SS; Kubar A
    Int J Infect Dis; 2011 Jan; 15(1):e44-7. PubMed ID: 21106428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradycardia related to ribavirin in four pediatric patients with Crimean-Congo hemorrhagic fever.
    Tezer H; Ozkaya Parlakay A; Gülhan B; Cetin I
    Vector Borne Zoonotic Dis; 2014 Jun; 14(6):464-5. PubMed ID: 24745325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis.
    Ascioglu S; Leblebicioglu H; Vahaboglu H; Chan KA
    J Antimicrob Chemother; 2011 Jun; 66(6):1215-22. PubMed ID: 21482564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is ribavirin prophylaxis effective for nosocomial transmission of Crimean-Congo hemorrhagic fever?
    Guner R; Hasanoglu I; Tasyaran MA; Yapar D; Keske S; Guven T; Yilmaz GR
    Vector Borne Zoonotic Dis; 2014 Aug; 14(8):601-5. PubMed ID: 25072991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of 400 Crimean-Congo hemorrhagic fever cases in an endemic area: is ribavirin treatment suitable?
    Duygu F; Kaya T; Baysan P
    Vector Borne Zoonotic Dis; 2012 Sep; 12(9):812-6. PubMed ID: 22007611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean-Congo hemorrhagic fever.
    Cevik MA; Elaldi N; Akinci E; Ongürü P; Erbay A; Buzgan T; Uzun R; Kubar A; Bodur H
    J Infect; 2008 Oct; 57(4):350-1. PubMed ID: 18722669
    [No Abstract]   [Full Text] [Related]  

  • 14. Systematic Review and Meta-analysis of Postexposure Prophylaxis for Crimean-Congo Hemorrhagic Fever Virus among Healthcare Workers.
    Ergönül Ö; Keske Ş; Çeldir MG; Kara İA; Pshenichnaya N; Abuova G; Blumberg L; Gönen M
    Emerg Infect Dis; 2018 Sep; 24(9):1642-1648. PubMed ID: 30124196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Crimean-Congo haemorrhagic fever successfully treated with therapeutic plasma exchange and ribavirin.
    Kurnaz F; Metan G; Coskun R; Kaynar L; Eser B; Doganay M
    Trop Doct; 2011 Jul; 41(3):181-2. PubMed ID: 21565949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEBATE (see Elaldi N et al, Efficacy of oral ribavirin treatment in Crimean-Congo haemorrhagic fever: a quasi-experimental study from Turkey. Journal of Infection 2009; 58: 238-244): Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever.
    Ergonul O
    J Infect; 2009 Oct; 59(4):284-6; author reply 286-9. PubMed ID: 19699762
    [No Abstract]   [Full Text] [Related]  

  • 17. Ribavirin Had Demonstrable Effects on the Crimean-Congo Hemorrhagic Fever Virus (CCHFV) Population and Load in a Patient With CCHF Infection.
    Espy N; Pérez-Sautu U; Ramírez de Arellano E; Negredo A; Wiley MR; Bavari S; Díaz Menendez M; Sánchez-Seco MP; Palacios G
    J Infect Dis; 2018 May; 217(12):1952-1956. PubMed ID: 29584885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antiviral efficacy of ribavirin, arbidol, and T-705 (favipiravir) in a mouse model for Crimean-Congo hemorrhagic fever.
    Oestereich L; Rieger T; Neumann M; Bernreuther C; Lehmann M; Krasemann S; Wurr S; Emmerich P; de Lamballerie X; Ölschläger S; Günther S
    PLoS Negl Trop Dis; 2014 May; 8(5):e2804. PubMed ID: 24786461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we really need ribavirin in the treatment of crimean-congo hemorrhagic Fever?
    Kalın G; Metan G; Demiraslan H; Doganay M
    J Chemother; 2014 Jun; 26(3):146-9. PubMed ID: 24091085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early use of ribavirin is beneficial in Crimean-Congo hemorrhagic fever.
    Ozbey SB; Kader Ç; Erbay A; Ergönül Ö
    Vector Borne Zoonotic Dis; 2014 Apr; 14(4):300-2. PubMed ID: 24689859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.